Cargando…

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases

CRISPR/Cas9 is now used widely to genetically modify the genomes of various species. The ability of CRISPR/Cas9 to delete DNA sequences and correct DNA mutations opens up a new avenue to treat genetic diseases that are caused by DNA mutations. In this review, we describe the advantages of using CRIS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Weili, Tu, Zhuchi, Sun, Qiang, Li, Xiao-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848312/ https://www.ncbi.nlm.nih.gov/pubmed/27199655 http://dx.doi.org/10.3389/fnmol.2016.00030

Ejemplares similares

CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
por: Tu, Zhuchi, et al.
Publicado: (2015)

Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022)

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
por: Shi, Yajun, et al.
Publicado: (2023)

CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys
por: Yang, Weili, et al.
Publicado: (2019)

Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos
por: Tu, Zhuchi, et al.
Publicado: (2017)

Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson’s disease
por: Qu, Jiangbo, et al.
Publicado: (2023)

Editing the Central Nervous System Through CRISPR/Cas9 Systems
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

An optimized CRISPR/Cas9 approach for precise genome editing in neurons
por: Fang, Huaqiang, et al.
Publicado: (2021)

In vivo Analysis of CRISPR/Cas9 Induced Atlastin Pathological Mutations in Drosophila
por: Montagna, Aldo, et al.
Publicado: (2020)

Ethical implications of fighting malaria with CRISPR/Cas9
por: Patrão Neves, Maria, et al.
Publicado: (2017)

Implications of CRISPR/Cas9 system in Hypertension and its related diseases
por: Sekar, Durairaj, et al.
Publicado: (2020)

A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use
por: Jiang, Long, et al.
Publicado: (2022)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023)

Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Implications of glial nitric oxide in neurodegenerative diseases
por: Yuste, Jose Enrique, et al.
Publicado: (2015)

Ryanodine Receptors in Autophagy: Implications for Neurodegenerative Diseases?
por: Vervliet, Tim
Publicado: (2018)

Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy
por: Santos, Renato, et al.
Publicado: (2019)

Using CRISPR/Cas9 to model human liver disease
por: Alves-Bezerra, Michele, et al.
Publicado: (2019)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges
por: Martinez-Lage, Marta, et al.
Publicado: (2018)

Targeting Cancer with CRISPR/Cas9-Based Therapy
por: Balon, Katarzyna, et al.
Publicado: (2022)

Applications of CRISPR-Cas9 mediated genome engineering
por: Yang, Xiao
Publicado: (2015)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
por: Jiang, Long, et al.
Publicado: (2022)

Multiplexed CRISPR/Cas9 Targeting of Genes Implicated in Retinal Regeneration and Degeneration
por: Unal Eroglu, Arife, et al.
Publicado: (2018)

Oligodendrogenesis and myelination tracing in a CRISPR/Cas9-engineered brain microphysiological system
por: Romero, July Carolina, et al.
Publicado: (2023)

CRISPR-Cas9/Cas12a biotechnology and application in bacteria
por: Yao, Ruilian, et al.
Publicado: (2018)

CRISPR/Cas9-Mediated Zebrafish Knock-in as a Novel Strategy to Study Midbrain-Hindbrain Boundary Development
por: Kesavan, Gokul, et al.
Publicado: (2017)

Modeling human disease in rodents by CRISPR/Cas9 genome editing
por: Birling, Marie-Christine, et al.
Publicado: (2017)

Editing the genome of hiPSC with CRISPR/Cas9: disease models
por: Bassett, Andrew R.
Publicado: (2017)

Applications of CRISPR/Cas9 in the Synthesis of Secondary Metabolites in Filamentous Fungi
por: Jiang, Chunmiao, et al.
Publicado: (2021)

Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020)

Type II CRISPR/Cas9 approach in the oncological therapy
por: Biagioni, A., et al.
Publicado: (2017)

Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
por: Li, Chenggong, et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
por: Ding, Shuai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_is707ce8chib35fjt29r4rg0l4